title: [The role of interval surgery in the treatment's strategy of advanced ovarian cancer].
abstract: The extent of cytoreductive surgery and the amount of residual disease are among the most important factors impacting the survival of women with advanced ovarian cancer. Chronology of treatment is still debating. In the French standard treatment, primary surgery remains the cornerstone and interval surgery is an option. Neoadjuvant chemotherapy followed by surgery may reduce morbidity and mortality. Nevertheless the impact of this strategy on survival is still controversial.
authors.affiliation: Centre régional de lutte contre le cancer Gauducheau, département d'oncologie chirurgicale, Saint-Herblain, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Jaffré
authors.forename: Virginie
authors.initials: V
authors.lastname: Bordes
authors.forename: Magali
authors.initials: M
authors.lastname: Dejode
authors.forename: François
authors.initials: F
authors.lastname: Dravet
authors.forename: Jean-Sébastien
authors.initials: JS
authors.lastname: Frénel
authors.forename: Dominique
authors.initials: D
authors.lastname: Berton-Rigaud
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Classe
mesh_terms: D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy / Q000379:methods*; D018365:Neoplasm, Residual; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery*